User profiles for Nishant Gupta

Nishant Gupta

- Verified email at ucmail.uc.edu - Cited by 3615

Dr. Nishant Kumar Gupta

- Verified email at arjunanatural.com - Cited by 690

[HTML][HTML] Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations

…, PJ de Vries, MD Frost, Z Fuchs, ES Gosnell, N Gupta… - Pediatric Neurology, 2021 - Elsevier
Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

Official American Thoracic Society/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management

FX McCormack, N Gupta, GR Finlay… - American journal of …, 2016 - atsjournals.org
Background: Lymphangioleiomyomatosis (LAM) is a rare cystic lung disease that primarily
affects women. The purpose of these guidelines is to provide recommendations for the …

Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management

C McCarthy, N Gupta, SR Johnson, JY Jane… - The Lancet …, 2021 - thelancet.com
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm
of women, characterised by infiltration of the lung parenchyma with abnormal smooth …

Landslide susceptibility zonation through ratings derived from artificial neural network

S Chauhan, M Sharma, MK Arora, NK Gupta - International Journal of …, 2010 - Elsevier
In the present study, Artificial Neural Network (ANN) has been implemented to derive
ratings of categories of causative factors, which are then integrated to produce a landslide …

Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management …

N Gupta, GA Finlay, RM Kotloff, C Strange… - American journal of …, 2017 - atsjournals.org
Background: Recommendations regarding key aspects related to the diagnosis and
pharmacological treatment of lymphangioleiomyomatosis (LAM) were recently published. We now …

[HTML][HTML] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

…, L Chung, RT Domsic, KR Flaherty, N Gupta… - Respiratory …, 2023 - Springer
Background Systemic sclerosis (SSc) is a rare, complex, connective tissue disorder. Interstitial
lung disease (ILD) is common in SSc, occurring in 35–52% of patients and accounting for …

Diffuse cystic lung disease. Part I

N Gupta, R Vassallo… - American journal of …, 2015 - atsjournals.org
The diffuse cystic lung diseases (DCLDs) are a group of pathophysiologically heterogenous
processes that are characterized by the presence of multiple spherical or irregularly shaped, …

Diffuse cystic lung disease. Part II

N Gupta, R Vassallo… - American journal of …, 2015 - atsjournals.org
The diffuse cystic lung diseases have a broad differential diagnosis. A wide variety of
pathophysiological processes spanning the spectrum from airway obstruction to lung remodeling …

Ziritaxestat, a novel autotaxin inhibitor, and lung function in idiopathic pulmonary fibrosis: the ISABELA 1 and 2 randomized clinical trials

…, J Fitzgerald, DG Manjarres, M Gotfried, N Gupta… - Jama, 2023 - jamanetwork.com
Importance There is a major need for effective, well-tolerated treatments for idiopathic
pulmonary fibrosis (IPF). Objective To assess the efficacy and safety of the autotaxin inhibitor …

Bioavailability enhancement of curcumin by complexation with phosphatidyl choline

NK Gupta, VK Dixit - Journal of pharmaceutical sciences, 2011 - Elsevier
Curcumin is a major constituent of rhizomes of Curcuma longa. Pharmacokinetic studies of
curcumin reveal its poor absorption through intestine. Objective of the present study was to …